0.931
Oncology Institute Inc Stock (TOI) Latest News
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% – Time to Sell? - Armenian Reporter
A groundbreaking project at the Oncology Institute in Shaare Zedek Medical Center - The Jerusalem Post
In the Green: Oncology Institute Inc (TOI) Closes at 0.82, Up/Down -7.68 from Previous Day - The Dwinnex
Oncology Institute Inc [TOI] Investment Appeal on the Rise - Knox Daily
Singapore Cancer Center opens in Cebu - SunStar Philippines
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying - Yahoo Finance
Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle
Oncology Institute Inc [TOI] Stock bought by Insider Hively Brad for $42500.0 - Knox Daily
The Oncology Institute Inc (TOI) had a good session last reading, didn’t it? - US Post News
Why The Oncology Institute (TOI) Is Skyrocketing So Far In 2025 - Insider Monkey
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Large Growth in Short Interest - MarketBeat
Cancer Care - Cone Health
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company - Simply Wall St
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire
The Oncology Institute Inc WT (TOIIW-Q) QuotePress Release - The Globe and Mail
HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute faces potential Nasdaq delisting - Investing.com
Florida Blue enhances cancer care for thousands of members - The Manila Times
Florida Blue Launches Breakthrough Cancer Care Program with The Oncology Institute Partnership - StockTitan
After Dana-Farber Split, Mass General Brigham Cuts New Cancer Path - Oncology News Central
Oncology institute director Brad Hively acquires $50,000 in stock - Investing.com
Oncology institute director Brad Hively acquires $50,000 in stock By Investing.com - Investing.com UK
Tomorrow’s Promise, Today’s Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment - Roswell Park Comprehensive Cancer Center
2024 Face of Hope: Carolina BioOncology Institute - Charlotte magazine
Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St
Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
RenovoRx Expands Phase III Pancreatic Cancer Trial with Major Cancer Institute Partnership - StockTitan
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
USF and TGH partner with robotics company to become the first to bring life-saving surgical technology to Tampa Bay - University of South Florida
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):